HCD20
Term · Oncology and biomedicine · MLC-T-ONC-003734
A substance being studied in the treatment of several types of lymphoma. It binds to the protein CD20, which is found on B cells (a type of immune system cell) and some types of lymphoma cells. This causes the immune system to kill the cancer cells. HCD20 is a type of monoclonal antibody. Also called hA20, IMMU-106, and veltuzumab.
| Identifier | MLC-T-ONC-003734 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | hA20; veltuzumab |
| Synonyms | IMMU-106 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003734",
"term": "HCD20",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of several types of lymphoma. It binds to the protein CD20, which is found on B cells (a type of immune system cell) and some types of lymphoma cells. This causes the immune system to kill the cancer cells. HCD20 is a type of monoclonal antibody. Also called hA20, IMMU-106, and veltuzumab.",
"expansions": [
"hA20",
"veltuzumab"
],
"synonyms": [
"IMMU-106"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/hcd20/"
}
Record 8,283 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.